Cardinal Health is a global healthcare services and products company that plays a vital role in the medical supply chain
It specializes in the distribution of pharmaceuticals and medical supplies to healthcare institutions, pharmacies, and patients. In addition to its distribution services, the company also manufactures and provides a wide range of medical and surgical products, including surgical gloves, apparel, and other healthcare-related items. Cardinal Health is committed to enhancing patient care by ensuring the availability of essential products and services, while also striving to improve the efficiency and effectiveness of healthcare delivery across various settings.
Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure.
Healthcare distributor and services company Cardinal Health (NYSECAH) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above analysts’ consensus estimates.
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting growth and recovery potential.
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty valuations ever.
Wall Street rebounded Friday following Thursday’s selloff, yet midday gains were still insufficient to prevent a second consecutive weekly decline for the S&P 500, currently down 1% for the week.
